申请人:Almirall, S.A.
公开号:EP2526945A1
公开(公告)日:2012-11-28
The present invention relates to a compound of formula (I), to the process for preparing such compounds and to their use in the treatment of a pathological condition or disease susceptible to amelioration by CRTh2 antagonist activity.
本发明涉及一种式(I)的化合物,以及制备这种化合物的方法,以及它们在治疗通过CRTh2拮抗活性可改善的病理状况或疾病中的应用。